{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:36Z","timestamp":1788383676143,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Trauma Research Department at the Medical Center of the Rockies"},{"DOI":"10.13039\/100001805","name":"Poudre Valley Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001805","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CSU Department of Environmental and Radiological Health Sciences"},{"name":"University of Colorado Health Northern Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11824-3","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:34:50Z","timestamp":1765373690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19"],"prefix":"10.1186","volume":"26","author":[{"given":"Luke A.","family":"Whitcomb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailey","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"LaVergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Natter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget A.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Gritsenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl K.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Gerbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Piehowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Henao-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Chicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru S.","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"11824_CR1","unstructured":"Mortality Analyses. Johns Hopkins Coronavirus Resource Center. Accessed December 7. 2024. https:\/\/coronavirus.jhu.edu\/data\/mortality"},{"issue":"3","key":"11824_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"11824_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361\u201379. https:\/\/doi.org\/10.1038\/s41579-023-00878-2.","journal-title":"Nat Rev Microbiol"},{"issue":"22","key":"11824_CR4","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934\u201346. https:\/\/doi.org\/10.1001\/jama.2023.8823.","journal-title":"JAMA"},{"issue":"8","key":"11824_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(23)00239-4","volume":"11","author":"M Parotto","year":"2023","unstructured":"Parotto M, Gy\u00f6ngy\u00f6si M, Howe K, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739\u201354. https:\/\/doi.org\/10.1016\/S2213-2600(23)00239-4.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"11824_CR6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","volume":"30","author":"M Cai","year":"2024","unstructured":"Cai M, Xie Y, Topol EJ, Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat Med. 2024;30(6):1564\u201373. https:\/\/doi.org\/10.1038\/s41591-024-02987-8.","journal-title":"Nat Med"},{"issue":"18","key":"11824_CR7","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","volume":"391","author":"EW Ely","year":"2024","unstructured":"Ely EW, Brown LM, Fineberg HV. Long covid defined. N Engl J Med. 2024;391(18):1746\u201353. https:\/\/doi.org\/10.1056\/NEJMsb2408466.","journal-title":"N Engl J Med"},{"key":"11824_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102000","author":"ICH Lam","year":"2023","unstructured":"Lam ICH, Wong CKH, Zhang R, et al. Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK. eClin Med. 2023. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102000.","journal-title":"eClin Med"},{"issue":"1","key":"11824_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-022-01167-4","volume":"4","author":"B Munipalli","year":"2022","unstructured":"Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. Sn Compr Clin Med. 2022;4(1):90. https:\/\/doi.org\/10.1007\/s42399-022-01167-4.","journal-title":"Sn Compr Clin Med"},{"key":"11824_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajmo.2024.100071","volume":"12","author":"S Umakanthan","year":"2024","unstructured":"Umakanthan S, Katwaroo AR, Bukelo M, et al. Post-acute sequelae of Covid-19: a system-wise approach on the effects of long-Covid-19. American Journal of Medicine Open. 2024;12:100071. https:\/\/doi.org\/10.1016\/j.ajmo.2024.100071.","journal-title":"American Journal of Medicine Open"},{"issue":"12","key":"11824_CR11","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1038\/s41564-024-01838-z","volume":"9","author":"JE Sinclair","year":"2024","unstructured":"Sinclair JE, Vedelago C, Ryan FJ, et al. Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function. Nat Microbiol. 2024;9(12):3135\u201347. https:\/\/doi.org\/10.1038\/s41564-024-01838-z.","journal-title":"Nat Microbiol"},{"issue":"4","key":"11824_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063969","volume":"13","author":"K Poole-Wright","year":"2023","unstructured":"Poole-Wright K, Guennouni I, Sterry O, Evans RA, Gaughran F, Chalder T. Fatigue outcomes following COVID-19: a systematic review and meta-analysis. BMJ Open. 2023;13(4):e063969. https:\/\/doi.org\/10.1136\/bmjopen-2022-063969.","journal-title":"BMJ Open"},{"issue":"11","key":"11824_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsend","year":"2020","unstructured":"Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784. https:\/\/doi.org\/10.1371\/journal.pone.0240784.","journal-title":"PLoS ONE"},{"key":"11824_CR14","doi-asserted-by":"publisher","unstructured":"Vu QM, Fitzpatrick AL, Cope JR, et al. Estimates of incidence and predictors of fatiguing illness after SARS-CoV-2 infection. Emerg Infect Dis. 2024;30(3). https:\/\/doi.org\/10.3201\/eid3003.231194.","DOI":"10.3201\/eid3003.231194"},{"issue":"16","key":"11824_CR15","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"Global Burden of Disease Long COVID Collaborators","year":"2022","unstructured":"Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent Fatigue, Cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604\u201315. https:\/\/doi.org\/10.1001\/jama.2022.18931.","journal-title":"JAMA"},{"issue":"11","key":"11824_CR16","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S2213-2600(21)00385-4","volume":"9","author":"AM Parker","year":"2021","unstructured":"Parker AM, Brigham E, Connolly B, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328\u201341. https:\/\/doi.org\/10.1016\/S2213-2600(21)00385-4.","journal-title":"Lancet Respir Med"},{"key":"11824_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169","author":"AD Proal","year":"2021","unstructured":"Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.698169.","journal-title":"Front Microbiol"},{"issue":"8","key":"11824_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae424","volume":"11","author":"X Zhang","year":"2024","unstructured":"Zhang X, Anzalone AJ, Dai D, et al. Chronic lung disease as a risk factor for long COVID in patients diagnosed with coronavirus disease 2019: a retrospective cohort study. Open Forum Infect Dis. 2024;11(8):ofae424. https:\/\/doi.org\/10.1093\/ofid\/ofae424.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"11824_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","volume":"29","author":"CD Russell","year":"2023","unstructured":"Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29(2):334\u201343. https:\/\/doi.org\/10.1038\/s41591-022-02156-9.","journal-title":"Nat Med"},{"key":"11824_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102588","volume":"71","author":"NA Glover","year":"2024","unstructured":"Glover NA, Ivanova O, Sathar F, et al. Lung outcomes and related risk factors in patients after SARS-CoV-2 infection: a hospitalised single-centre cohort from Johannesburg, South Africa. eClinicalMedicine. 2024;71:102588. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102588.","journal-title":"eClinicalMedicine"},{"issue":"8","key":"11824_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2213-2600(23)00159-5","volume":"11","author":"SJ Singh","year":"2023","unstructured":"Singh SJ, Baldwin MM, Daynes E, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med. 2023;11(8):709\u201325. https:\/\/doi.org\/10.1016\/S2213-2600(23)00159-5.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"11824_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16916-w","volume":"23","author":"EL Hill","year":"2023","unstructured":"Hill EL, Mehta HB, Sharma S, et al. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH recover study. BMC Public Health. 2023;23(1):2103. https:\/\/doi.org\/10.1186\/s12889-023-16916-w.","journal-title":"BMC Public Health"},{"issue":"4","key":"11824_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041328","volume":"12","author":"LG Fritsche","year":"2023","unstructured":"Fritsche LG, Jin W, Admon AJ, Mukherjee B. Characterizing and predicting post-acute sequelae of SARS CoV-2 infection (PASC) in a large academic medical center in the US. J Clin Med. 2023;12(4):1328. https:\/\/doi.org\/10.3390\/jcm12041328.","journal-title":"J Clin Med"},{"issue":"4","key":"11824_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","volume":"127","author":"JD McFadyen","year":"2020","unstructured":"McFadyen JD, Stevens H, Peter K. The emerging threat of (Micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571\u201387. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317447.","journal-title":"Circ Res"},{"issue":"6","key":"11824_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","volume":"34","author":"S Turner","year":"2023","unstructured":"Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34(6):321\u201344. https:\/\/doi.org\/10.1016\/j.tem.2023.03.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"11824_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","volume":"22","author":"EM Conway","year":"2022","unstructured":"Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22(10):639\u201349. https:\/\/doi.org\/10.1038\/s41577-022-00762-9.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"11824_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/thoraxjnl-2020-216243","volume":"76","author":"J Loo","year":"2021","unstructured":"Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76(4):412\u201320. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216243.","journal-title":"Thorax"},{"key":"11824_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.861703","author":"C Wang","year":"2022","unstructured":"Wang C, Yu C, Jing H, et al. Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol. 2022. https:\/\/doi.org\/10.3389\/fcimb.2022.861703.","journal-title":"Front Cell Infect Microbiol"},{"issue":"20","key":"11824_CR29","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):5500\u201329. https:\/\/doi.org\/10.1016\/j.cell.2024.07.054.","journal-title":"Cell"},{"key":"11824_CR30","unstructured":"Basu-Ray I, Almaddah N, k, Vaqar S, Soos MP. Cardiac Manifestations of Coronavirus (COVID-19). In: StatPearls. StatPearls Publishing. 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556152\/. Accessed December 7, 2024."},{"issue":"3","key":"11824_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9030047","volume":"9","author":"CCE Lee","year":"2021","unstructured":"Lee CCE, Ali K, Connell D, et al. COVID-19-associated cardiovascular complications. Dis. 2021;9(3):47. https:\/\/doi.org\/10.3390\/diseases9030047.","journal-title":"Dis"},{"issue":"12","key":"11824_CR32","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2022.2411","volume":"327","author":"J Abbasi","year":"2022","unstructured":"Abbasi J. The COVID heart\u2014one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks. JAMA. 2022;327(12):1113\u20134. https:\/\/doi.org\/10.1001\/jama.2022.2411.","journal-title":"JAMA"},{"issue":"1","key":"11824_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/cid\/ciad469","volume":"78","author":"JT Lim","year":"2024","unstructured":"Lim JT, Liang En W, Tay AT, et al. Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors: a retrospective cohort study. Clin Infect Dis. 2024;78(1):70\u20139. https:\/\/doi.org\/10.1093\/cid\/ciad469.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11824_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583\u201390. https:\/\/doi.org\/10.1038\/s41591-022-01689-3.","journal-title":"Nat Med"},{"key":"11824_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101619","volume":"53","author":"W Wang","year":"2022","unstructured":"Wang W, Wang CY, Wang SI, Wei JCC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinMed. 2022;53:101619. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101619.","journal-title":"EClinMed"},{"issue":"1","key":"11824_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06359-2","volume":"21","author":"SM LaVergne","year":"2021","unstructured":"LaVergne SM, Stromberg S, Baxter BA, et al. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis. 2021;21(1):677. https:\/\/doi.org\/10.1186\/s12879-021-06359-2.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11824_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.annemergmed.2020.07.022","volume":"76","author":"AD Haimovich","year":"2020","unstructured":"Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442\u201353. https:\/\/doi.org\/10.1016\/j.annemergmed.2020.07.022.","journal-title":"Ann Emerg Med"},{"issue":"8","key":"11824_CR38","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/nprot.2017.054","volume":"12","author":"H Keshishian","year":"2017","unstructured":"Keshishian H, Burgess MW, Specht H, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017;12(8):1683\u2013701. https:\/\/doi.org\/10.1038\/nprot.2017.054.","journal-title":"Nat Protoc"},{"key":"11824_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jchromb.2016.01.015","volume":"1021","author":"C Wu","year":"2016","unstructured":"Wu C, Duan J, Liu T, Smith RD, Qian WJ. Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1021:57\u201368. https:\/\/doi.org\/10.1016\/j.jchromb.2016.01.015.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"24","key":"11824_CR40","first-page":"11725","volume":"85","author":"Y Simon","year":"2013","unstructured":"Simon Y, Lowenthal MS, Kilpatrick LE, et al. Metabolite Profiling of a NIST Standard Reference Material for Human Plasma (SRM 1950) \u2013 GC\/MS, LC\/MS, NMR and Clinical Laboratory Analyses, Libraries and Web-based resources. NIST. 2013;85(24):11725\u201331.","journal-title":"NIST"},{"issue":"3","key":"11824_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biom11030383","volume":"11","author":"O Alcazar","year":"2021","unstructured":"Alcazar O, Hernandez LF, Nakayasu ES, et al. Parallel multi-omics in High-Risk subjects for the identification of integrated biomarker signatures of type 1 diabetes. Biomolecules. 2021;11(3):383. https:\/\/doi.org\/10.3390\/biom11030383.","journal-title":"Biomolecules"},{"issue":"7","key":"11824_CR42","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","volume":"13","author":"P Mertins","year":"2018","unstructured":"Mertins P, Tang LC, Krug K, et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat Protoc. 2018;13(7):1632\u201361. https:\/\/doi.org\/10.1038\/s41596-018-0006-9.","journal-title":"Nat Protoc"},{"issue":"23","key":"11824_CR43","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1093\/bioinformatics\/btv437","volume":"31","author":"BC Gibbons","year":"2015","unstructured":"Gibbons BC, Chambers MC, Monroe ME, Tabb DL, Payne SH. Correcting systematic bias and instrument measurement drift with mzRefinery. Bioinformatics. 2015;31(23):3838\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btv437.","journal-title":"Bioinformatics"},{"issue":"3","key":"11824_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.compbiolchem.2008.02.006","volume":"32","author":"ME Monroe","year":"2008","unstructured":"Monroe ME, Shaw JL, Daly DS, Adkins JN, Smith RD. MASIC: a software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(\/MS) features. Comput Biol Chem. 2008;32(3):215\u20137. https:\/\/doi.org\/10.1016\/j.compbiolchem.2008.02.006.","journal-title":"Comput Biol Chem"},{"issue":"3","key":"11824_CR45","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1021\/acs.jproteome.8b00760","volume":"18","author":"KG Stratton","year":"2019","unstructured":"Stratton KG, Webb-Robertson BJM, McCue LA, et al. Pmartr: quality control and statistics for mass spectrometry-based biological data. J Proteome Res. 2019;18(3):1418\u201325. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00760.","journal-title":"J Proteome Res"},{"issue":"11","key":"11824_CR46","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1021\/pr1005247","volume":"9","author":"BJM Webb-Robertson","year":"2010","unstructured":"Webb-Robertson BJM, McCue LA, Waters KM, et al. Combined statistical analyses of peptide intensities and peptide occurrences improves identification of significant peptides from MS-based proteomics data. J Proteome Res. 2010;9(11):5748\u201356. https:\/\/doi.org\/10.1021\/pr1005247.","journal-title":"J Proteome Res"},{"issue":"20","key":"11824_CR47","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btr479","volume":"27","author":"MM Matzke","year":"2011","unstructured":"Matzke MM, Waters KM, Metz TO, et al. Improved quality control processing of peptide-centric LC-MS proteomics data. Bioinformatics. 2011;27(20):2866\u201372. https:\/\/doi.org\/10.1093\/bioinformatics\/btr479.","journal-title":"Bioinformatics"},{"issue":"24","key":"11824_CR48","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1002\/pmic.201100078","volume":"11","author":"BJM Webb-Robertson","year":"2011","unstructured":"Webb-Robertson BJM, Matzke MM, Jacobs JM, Pounds JG, Waters KM. A statistical selection strategy for normalization procedures in LC-MS proteomics experiments through dataset-dependent ranking of normalization scaling factors. Proteomics. 2011;11(24):4736\u201341. https:\/\/doi.org\/10.1002\/pmic.201100078.","journal-title":"Proteomics"},{"issue":"12","key":"11824_CR49","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/bioinformatics\/bts193","volume":"28","author":"X Wang","year":"2012","unstructured":"Wang X, Anderson GA, Smith RD, Dabney AR. A hybrid approach to protein differential expression in mass spectrometry-based proteomics. Bioinformatics. 2012;28(12):1586\u201391. https:\/\/doi.org\/10.1093\/bioinformatics\/bts193.","journal-title":"Bioinformatics"},{"issue":"4","key":"11824_CR50","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18(4):e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27.","journal-title":"Immune Netw"},{"issue":"1","key":"11824_CR51","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.18295\/2075-0528.1648","volume":"15","author":"WG Land","year":"2015","unstructured":"Land WG. The role of damage-associated molecular patterns in human diseases. Sultan Qaboos Univ Med J. 2015;15(1):e9-21.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"11824_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","volume":"81","author":"X Wang","year":"2018","unstructured":"Wang X, Khalil RA, Matrix, Metalloproteinases. Vascular Remodeling, and vascular disease. Adv Pharmacol San Diego Calif. 2018;81:241\u2013330. https:\/\/doi.org\/10.1016\/bs.apha.2017.08.002.","journal-title":"Adv Pharmacol San Diego Calif"},{"key":"11824_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1009908","author":"L Prieto-Fern\u00e1ndez","year":"2022","unstructured":"Prieto-Fern\u00e1ndez L, Men\u00e9ndez ST, Otero-Rosales M, et al. Pathobiological functions and clinical implications of Annexin dysregulation in human cancers. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.1009908.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"11824_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1152\/physrev.00030.2001","volume":"82","author":"V Gerke","year":"2002","unstructured":"Gerke V, Moss SE. Annexins. From structure to function. Physiol Rev. 2002;82(2):331\u201371. https:\/\/doi.org\/10.1152\/physrev.00030.2001.","journal-title":"Physiol Rev"},{"key":"11824_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139\u201362. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101323.","journal-title":"Annu Rev Immunol"},{"issue":"33","key":"11824_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102034118","volume":"118","author":"H Yang","year":"2021","unstructured":"Yang H, Zeng Q, Silverman HA, et al. HMGB1 released from nociceptors mediates inflammation. Proc Natl Acad Sci U S A. 2021;118(33):e2102034118. https:\/\/doi.org\/10.1073\/pnas.2102034118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"0","key":"11824_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbagrm.2009.11.019","volume":"1799","author":"H Yang","year":"2010","unstructured":"Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010;1799(0):149\u201356. https:\/\/doi.org\/10.1016\/j.bbagrm.2009.11.019.","journal-title":"Biochim Biophys Acta"},{"key":"11824_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00484","author":"H Yang","year":"2020","unstructured":"Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00484.","journal-title":"Front Immunol"},{"issue":"3","key":"11824_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.13722","volume":"171","author":"P Xia","year":"2024","unstructured":"Xia P, Ji X, Yan L, Lian S, Chen Z, Luo Y. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity. Immunology. 2024;171(3):365\u201376. https:\/\/doi.org\/10.1111\/imm.13722.","journal-title":"Immunology"},{"key":"11824_CR60","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41598-018-37684-3","volume":"9","author":"LAN Crowe","year":"2019","unstructured":"Crowe LAN, McLean M, Kitson SM, et al. S100A8 & S100A9: alarmin mediated inflammation in tendinopathy. Sci Rep. 2019;9:1463. https:\/\/doi.org\/10.1038\/s41598-018-37684-3.","journal-title":"Sci Rep"},{"issue":"2","key":"11824_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","volume":"32","author":"MM Averill","year":"2012","unstructured":"Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol. 2012;32(2):223\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.111.236927.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11824_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298. https:\/\/doi.org\/10.3389\/fimmu.2018.01298.","journal-title":"Front Immunol"},{"key":"11824_CR63","doi-asserted-by":"publisher","unstructured":"Shankar M, Uwamahoro N, Holmberg S et al. S100A8\/A9 modulates inflammatory collateral tissue damage during intraperitoneal origin systemic candidiasis. bioRxiv https:\/\/doi.org\/10.1101\/2020.03.30.017491. Preprint posted online 21 April 2020.","DOI":"10.1101\/2020.03.30.017491"},{"key":"11824_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113421","volume":"169","author":"T Morikawa-Ichinose","year":"2022","unstructured":"Morikawa-Ichinose T, Fujimura Y, Kumazoe M, Onda H, Miura D, Tachibana H. Inflammatory markers S100A8\/A9 and metabolic alteration for evaluating signs of early phase toxicity of anticancer agent treatment. Food Chem Toxicol. 2022;169:113421. https:\/\/doi.org\/10.1016\/j.fct.2022.113421.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"11824_CR65","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.170.6.3233","volume":"170","author":"C Ryckman","year":"2003","unstructured":"Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8\/A9 induce neutrophil chemotaxis and adhesion 1. J Immunol. 2003;170(6):3233\u201342. https:\/\/doi.org\/10.4049\/jimmunol.170.6.3233.","journal-title":"J Immunol"},{"issue":"3","key":"11824_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221\u201333. https:\/\/doi.org\/10.1038\/nrm2125.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"11824_CR67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/TA.0000000000004190","volume":"96","author":"TW Costantini","year":"2024","unstructured":"Costantini TW, Kornblith LZ, Pritts T, Coimbra R. The intersection of coagulation activation and inflammation after injury: what you need to know. J Trauma Acute Care Surg. 2024;96(3):347\u201356. https:\/\/doi.org\/10.1097\/TA.0000000000004190.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"11824_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.coi.2012.09.008","volume":"24","author":"S Caielli","year":"2012","unstructured":"Caielli S, Banchereau J, Pascual V. Neutrophils come of age in chronic inflammation. Curr Opin Immunol. 2012;24(6):671\u20137. https:\/\/doi.org\/10.1016\/j.coi.2012.09.008.","journal-title":"Curr Opin Immunol"},{"key":"11824_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00113","volume":"9","author":"C Rosales","year":"2018","unstructured":"Rosales C. Neutrophil. A cell with many roles in inflammation or several cell types? Front Physiol. 2018;9:113. https:\/\/doi.org\/10.3389\/fphys.2018.00113.","journal-title":"Front Physiol"},{"issue":"10","key":"11824_CR70","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200161","volume":"10","author":"T Dehghani","year":"2020","unstructured":"Dehghani T, Panitch A. Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle. Open Biol. 2020;10(10):200161. https:\/\/doi.org\/10.1098\/rsob.200161.","journal-title":"Open Biol"},{"issue":"1","key":"11824_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01623-4","volume":"21","author":"A Kruger","year":"2022","unstructured":"Kruger A, Vlok M, Turner S, et al. Proteomics of fibrin amyloid microclots in long COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022;21(1):190. https:\/\/doi.org\/10.1186\/s12933-022-01623-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"11824_CR72","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/BCJ20220016","volume":"479","author":"DB Kell","year":"2022","unstructured":"Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537\u201359. https:\/\/doi.org\/10.1042\/BCJ20220016.","journal-title":"Biochem J"},{"issue":"13","key":"11824_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310458","volume":"24","author":"D Tsilingiris","year":"2023","unstructured":"Tsilingiris D, Vallianou NG, Karampela I, et al. Laboratory findings and biomarkers in long COVID: what do we know so far? insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int J Mol Sci. 2023;24(13):10458. https:\/\/doi.org\/10.3390\/ijms241310458.","journal-title":"Int J Mol Sci"},{"key":"11824_CR74","doi-asserted-by":"publisher","unstructured":"Turner S, Naidoo CA, Usher TJ et al. Increased levels of inflammatory molecules in blood of long COVID patients point to thrombotic endotheliitis. medRxiv. Preprint posted online 13 October 2022. https:\/\/doi.org\/10.1101\/2022.10.13.22281055.","DOI":"10.1101\/2022.10.13.22281055"},{"issue":"1","key":"11824_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01579-5","volume":"21","author":"E Pretorius","year":"2022","unstructured":"Pretorius E, Venter C, Laubscher GJ, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21(1):148. https:\/\/doi.org\/10.1186\/s12933-022-01579-5.","journal-title":"Cardiovasc Diabetol"},{"key":"11824_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303971","author":"SM LaVergne","year":"2024","unstructured":"LaVergne SM, Dutt TS, McFann K, et al. Persistent CD8\u2009+\u2009T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2023.1303971.","journal-title":"Front Immunol"},{"issue":"6","key":"11824_CR77","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jaci.2020.01.022","volume":"145","author":"MW Johansson","year":"2020","unstructured":"Johansson MW, McKernan EM, Fichtinger PS, et al. \u03b1IIb-integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(6):1699\u2013701. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.022.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"11824_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0709-6","volume":"12","author":"J Huang","year":"2019","unstructured":"Huang J, Li X, Shi X, et al. Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. 2019;12(1):26. https:\/\/doi.org\/10.1186\/s13045-019-0709-6.","journal-title":"J Hematol Oncol"},{"issue":"24","key":"11824_CR79","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","volume":"24","author":"AD Blann","year":"2003","unstructured":"Blann AD, Nadar SK, Lip GYH. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003;24(24):2166\u201379. https:\/\/doi.org\/10.1016\/j.ehj.2003.08.021.","journal-title":"Eur Heart J"},{"key":"11824_CR80","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.thromres.2022.06.014","volume":"216","author":"R M\u00fcller","year":"2022","unstructured":"M\u00fcller R, Rink G, Uzun G, et al. Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors. Thromb Res. 2022;216:120\u20134. https:\/\/doi.org\/10.1016\/j.thromres.2022.06.014.","journal-title":"Thromb Res"},{"issue":"5","key":"11824_CR81","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/01.STR.0000013739.82306.7F","volume":"33","author":"S Kamath","year":"2002","unstructured":"Kamath S, Blann AD, Caine GJ, Gurney D, Chin BSP, Lip GYH. Platelet P-selectin levels in relation to plasma soluble P-selectin and \u03b2-thromboglobulin levels in atrial fibrillation. Stroke. 2002;33(5):1237\u201342. https:\/\/doi.org\/10.1161\/01.STR.0000013739.82306.7F.","journal-title":"Stroke"},{"issue":"2","key":"11824_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1525-1594.2010.01051.x","volume":"35","author":"Q Lu","year":"2011","unstructured":"Lu Q, Malinauskas RA. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. Artif Organs. 2011;35(2):137\u201344. https:\/\/doi.org\/10.1111\/j.1525-1594.2010.01051.x.","journal-title":"Artif Organs"},{"issue":"1","key":"11824_CR83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood.V70.1.307.307","volume":"70","author":"S Shattil","year":"1987","unstructured":"Shattil S, Cunningham M, Hoxie J. Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry. Blood. 1987;70(1):307\u201315. https:\/\/doi.org\/10.1182\/blood.V70.1.307.307.","journal-title":"Blood"},{"issue":"1","key":"11824_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19126-8","volume":"8","author":"AL S\u00f6dergren","year":"2018","unstructured":"S\u00f6dergren AL, Ramstr\u00f6m S. Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol. Sci Rep. 2018;8(1):1441. https:\/\/doi.org\/10.1038\/s41598-017-19126-8.","journal-title":"Sci Rep"},{"issue":"1","key":"11824_CR85","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41598-024-51908-9","volume":"14","author":"SB MJ","year":"2024","unstructured":"MJ SB, Chacko B, Selvarajan S, et al. Biomarkers of coagulation, endothelial, platelet function, and fibrinolysis in patients with COVID-19: a prospective study. Sci Rep. 2024;14(1):2011. https:\/\/doi.org\/10.1038\/s41598-024-51908-9.","journal-title":"Sci Rep"},{"issue":"5","key":"11824_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268296","volume":"17","author":"WO Osburn","year":"2022","unstructured":"Osburn WO, Smith K, Yanek L, et al. Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19. PLoS ONE. 2022;17(5):e0268296. https:\/\/doi.org\/10.1371\/journal.pone.0268296.","journal-title":"PLoS ONE"},{"issue":"6","key":"11824_CR87","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4161\/viru.25221","volume":"4","author":"SM Graham","year":"2013","unstructured":"Graham SM, Mwilu R, Liles WC. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection. Virulence. 2013;4(6):564\u201371. https:\/\/doi.org\/10.4161\/viru.25221.","journal-title":"Virulence"},{"issue":"5","key":"11824_CR88","first-page":"952","volume":"144","author":"RR Johnson-Tidey","year":"1994","unstructured":"Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol. 1994;144(5):952\u201361.","journal-title":"Am J Pathol"},{"issue":"5","key":"11824_CR89","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1515\/CCLM.2004.082","volume":"42","author":"J Kappelmayer","year":"2004","unstructured":"Kappelmayer J, Nagy B, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med. 2004;42(5):475\u201386. https:\/\/doi.org\/10.1515\/CCLM.2004.082.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"11824_CR90","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1084\/jem.191.8.1413","volume":"191","author":"PS Frenette","year":"2000","unstructured":"Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (Psgl-1) is expressed on platelets and can mediate platelet\u2013endothelial interactions in vivo. J Exp Med. 2000;191(8):1413\u201322.","journal-title":"J Exp Med"},{"issue":"5","key":"11824_CR91","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/ATVBAHA.107.140442","volume":"27","author":"P da Costa Martins","year":"2007","unstructured":"da Costa Martins P, Garc\u00eda-Vallejo JJ, van Thienen JV, et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol. 2007;27(5):1023\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.107.140442.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"11824_CR92","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover SP, Mackman N. Tissue factor. Arterioscler Thromb Vasc Biol. 2018;38(4):709\u201325. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309846.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"11824_CR93","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/jth.14246","volume":"16","author":"H Zelaya","year":"2018","unstructured":"Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling. J Thromb Haemost. 2018;16(10):1941\u201352. https:\/\/doi.org\/10.1111\/jth.14246.","journal-title":"J Thromb Haemost"},{"issue":"13","key":"11824_CR94","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878\u201387. https:\/\/doi.org\/10.1182\/blood-2008-06-165845.","journal-title":"Blood"},{"issue":"11","key":"11824_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115941","volume":"25","author":"X Qiu","year":"2024","unstructured":"Qiu X, Nair MG, Jaroszewski L, Godzik A. Deciphering abnormal platelet subpopulations in COVID-19, sepsis and systemic lupus erythematosus through machine learning and single-cell transcriptomics. Int J Mol Sci. 2024;25(11):5941. https:\/\/doi.org\/10.3390\/ijms25115941.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11824_CR96","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8516","volume":"6","author":"A Mourad","year":"2023","unstructured":"Mourad A, Thibault D, Holland TL, et al. Dexamethasone for inpatients with COVID-19 in a national cohort. JAMA Netw Open. 2023;6(4):e238516. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8516.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"11824_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12124158","volume":"12","author":"D Badenes Bonet","year":"2023","unstructured":"Badenes Bonet D, Caguana V\u00e9lez OA, Duran Jord\u00e0 X, et al. Treatment of COVID-19 during the acute phase in hospitalized patients decreases post-acute sequelae of COVID-19. J Clin Med. 2023;12(12):4158. https:\/\/doi.org\/10.3390\/jcm12124158.","journal-title":"J Clin Med"},{"issue":"10","key":"11824_CR98","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1016\/j.jtha.2023.07.012","volume":"21","author":"JM Connors","year":"2023","unstructured":"Connors JM, Ari\u00ebns RAS. Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Thromb Haemost. 2023;21(10):2697\u2013701. https:\/\/doi.org\/10.1016\/j.jtha.2023.07.012.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"11824_CR99","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11239-025-03096-0","volume":"58","author":"F Frost","year":"2025","unstructured":"Frost F, Rivera-Caravaca JM, Lip GYH. The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID\/post-acute sequelae of SARS-CoV-2 infection. J Thromb Thrombolysis. 2025;58(4):585\u20139. https:\/\/doi.org\/10.1007\/s11239-025-03096-0.","journal-title":"J Thromb Thrombolysis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11824-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11824-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11824-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:56:27Z","timestamp":1768366587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-11824-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11824"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11824-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7132372\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Colorado State University\u2019s Institutional Review Board (IRB), protocol# 20\u201310063\u00a0H and Colorado Multiple IRB protocol# 20-6043. All participants provided written informed consent prior to the first study visit. The study was conducted in accordance with the Helsinki Declaration and its 2013 amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}